This finding suggests that adiponectin could potentially contribute to the prevention of liver fibrosis, a condition frequently linked to coagulation abnormalities in individuals with MASLD. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.